Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
268.73
+2.43 (0.91%)
At close: Oct 27, 2026, 4:00 PM EDT
268.53
-0.20 (-0.07%)
After-hours: Oct 27, 2026, 7:35 PM EDT

Johnson & Johnson Revenue

Johnson & Johnson had revenue of $25.40B in the quarter ending September 27, 2026, with 5.86% growth. This brings the company's total for the last twelve months to $99.34B, up 7.80% year-over-year. In the year 2025, Johnson & Johnson had annual revenue of $94.19B with 6.05% growth. That makes Johnson & Johnson the 85th largest company in the world by revenue and 38th in the United States.

Revenue (ttm)
$99.34B
Revenue Growth
+7.80%
P/S Ratio
6.51
Revenue / Employee
$718,777
Employees
138,200
Market Cap
646.92B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Innovative Medicine 60.40B 64.1%
  • MedTech 33.79B 35.9%

By Geography

Chart
  • United States 53.75B 57.1%
  • Europe 21.54B 22.9%
  • Asia Pacific, Africa 14.03B 14.9%
  • Western Hemisphere ex-US 4.88B 5.2%
Fiscal year ended Dec 28, 2025 See the full Johnson & Johnson breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 28, 202594.19B5.37B6.05%
Dec 29, 202488.82B3.66B4.30%
Dec 31, 202385.16B5.17B6.46%
Jan 1, 202379.99B1.25B1.59%
Jan 2, 202278.74B-3.84B-4.65%
Jan 3, 202182.58B525.00M0.64%
Dec 29, 201982.06B478.00M0.59%
Dec 30, 201881.58B5.13B6.71%
Dec 31, 201776.45B4.56B6.34%
Jan 1, 201771.89B1.82B2.59%
Jan 3, 201670.07B-4.26B-5.73%
Dec 28, 201474.33B3.02B4.23%
Dec 29, 201371.31B4.09B6.08%
Dec 30, 201267.22B2.19B3.37%
Jan 1, 201265.03B3.44B5.59%
Jan 2, 201161.59B-310.00M-0.50%
Jan 3, 201061.90B-1.85B-2.90%
Dec 28, 200863.75B2.65B4.34%
Dec 30, 200761.10B7.77B14.57%
Dec 31, 200653.32B2.81B5.56%
Jan 1, 200650.51B3.17B6.69%
Jan 2, 200547.35B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Eli Lilly and Company79.67B
Merck & Co.66.57B
AbbVie64.39B
Pfizer63.70B
AstraZeneca61.37B
Novartis AG56.69B
Novo Nordisk50.34B
Bristol-Myers Squibb Company49.19B
Revenue Rankings